Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3240–3243. doi: 10.1128/jcm.35.12.3240-3243.1997

Use of the BioMerieux ID 32C yeast identification system for identification of aerobic actinomycetes of medical importance.

D B Muir 1, R C Pritchard 1
PMCID: PMC230154  PMID: 9399526

Abstract

The BioMerieux ID 32C Yeast Identification System was examined to determine its usefulness as a rapid method for the identification of medically important aerobic actinomycetes. More than 290 strains were tested by this method and the results were compared to those obtained by conventional methods. It was found that aerobic actinomycetes could be differentiated to species level in 7 days by the ID 32C system.

Full Text

The Full Text of this article is available as a PDF (91.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berd D. Laboratory identification of clinically important aerobic actinomycetes. Appl Microbiol. 1973 Apr;25(4):665–681. doi: 10.1128/am.25.4.665-681.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biehle J. R., Cavalieri S. J., Felland T., Zimmer B. L. Novel method for rapid identification of Nocardia species by detection of preformed enzymes. J Clin Microbiol. 1996 Jan;34(1):103–107. doi: 10.1128/jcm.34.1.103-107.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boiron P., Provost F. Enzymatic characterization of Nocardia spp. and related bacteria by API ZYM profile. Mycopathologia. 1990 Apr;110(1):51–56. doi: 10.1007/BF00442770. [DOI] [PubMed] [Google Scholar]
  4. Carson M., Hellyar A. Opacification of Middlebrook agar as an aid in distinguishing Nocardia farcinica within the Nocardia asteroides complex. J Clin Microbiol. 1994 Sep;32(9):2270–2271. doi: 10.1128/jcm.32.9.2270-2271.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flores M., Desmond E. Opacification of Middlebrook agar as an aid in identification of Nocardia farcinica. J Clin Microbiol. 1993 Nov;31(11):3040–3041. doi: 10.1128/jcm.31.11.3040-3041.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mishra S. K., Gordon R. E., Barnett D. A. Identification of nocardiae and streptomycetes of medical importance. J Clin Microbiol. 1980 Jun;11(6):728–736. doi: 10.1128/jcm.11.6.728-736.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Okanishi M., Akagawa H., Umezawa H. An evaluation of taxonomic criteria in streptomycetes on the basis of deoxyribonucleic acid homology. J Gen Microbiol. 1972 Aug;72(1):49–58. doi: 10.1099/00221287-72-1-49. [DOI] [PubMed] [Google Scholar]
  8. Richter S., Kane J., Summerbell R. C., Krajden S., Diena B. Application of the API YeastIdent system in determining the enzymatic profiles of Nocardia asteroides isolates. Mycopathologia. 1995;129(1):1–4. doi: 10.1007/BF01139330. [DOI] [PubMed] [Google Scholar]
  9. Wallace R. J., Jr, Brown B. A., Tsukamura M., Brown J. M., Onyi G. O. Clinical and laboratory features of Nocardia nova. J Clin Microbiol. 1991 Nov;29(11):2407–2411. doi: 10.1128/jcm.29.11.2407-2411.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES